Prokidney Corp.

Ownership Transactions Reported by 25 Insiders

Symbol
PROK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2000 Frontis Plaza Blvd., Suite 250, Winston Salem, North Carolina

Insiders trading volume in the past year

Prokidney Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Control Empresarial de Capitales S.A. de C.V. Other*, 10%+ Owner $173M +$20.3M +13.2% Jun 11, 2024
Pablo G. Legorreta Director, 10%+ Owner $171M +$54.7M +47.2% Jun 13, 2024
SC Master Holdings, LLC 10%+ Owner $17.4M Jul 11, 2022
Aaron Cowen 10%+ Owner $5.3M Mar 31, 2023
Darin J. Weber Chief Regulatory Officer $1.17M -$354K -23.3% Jul 26, 2024
Todd Girolamo Chief Legal Officer $839K Jul 31, 2024
SCS Sponsor III LLC Former Director and 10% Owner Jul 11, 2022
John Maraganore Director Jun 29, 2023
William F. Doyle Director May 30, 2024
Santos Jose Ignacio Jimenez Director May 30, 2024
James Coulston Chief Financial Officer Mar 1, 2024
Libbie Parker McKenzie Chief Medical Officer Jan 16, 2023
Deepak Jain Chief Operating Officer Jan 16, 2023
Brian JG Pereira Director May 30, 2024
Bruce Culleton Chief Executive Officer, Director Dec 3, 2023
Alan Lotvin Director May 30, 2024
Jennifer A. Fox Director Sep 3, 2024
Timothy Bertram Chief Executive Officer, Director Jan 16, 2023
Mary Weger Chief People Officer Jan 16, 2023
Chamath Palihapitiya Former 10% Owner -$27.6M Nov 19, 2023
Uma Sinha Director May 30, 2024
Ulrich Peter Alfred Ernst EVP, Technical Operations Apr 1, 2024
Shoney Katz Director of Research Jun 29, 2021
Semigran Marc Director Jun 29, 2021
James Ryans Chief Financial Officer Jun 29, 2021

Recent Insider Transactions by Companies or Individuals for Prokidney Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.